Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jul 2026 for Angiodynamics INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Karen A. Licitra: trading record in brief
Filings by Karen A. Licitra span 2 companies, the busiest being Angiodynamics Inc and SI-BONE, Inc. In total, 7 filings cover trades dated from 25 June 2021 to 15 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 22 July 2026 with a share grant in Angiodynamics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Karen A. Licitra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
11,887 shares0Common StockSEC:0001140361-26-029340:0
17,675 shares0Common StockSEC:0001140361-25-026455:0
20,541 shares0Common StockSEC:0001140361-24-033628:0
17,041 shares0Common StockSEC:0001140361-23-035719:0
7,060 shares0Common StockSEC:0001567619-22-014361:0
5,738 shares0Common StockSEC:0001567619-21-013921:0
10,297 shares@ US$4.32100.0% of flowCommon StockSEC:0001562180-21-004531:0
7 of 7 declarations
